Table 1.
Association between clinicopathological characteristics and expression of lncRNA-NBAT-1 in the esophageal cancer patients (n=67)
| Characteristics | n | lncRNA-NBAT-1 | P-value | |
|---|---|---|---|---|
|
| ||||
| High expression | Low expression | |||
| Sex | 0.548 | |||
| Male | 37 | 17 | 20 | |
| Female | 30 | 16 | 14 | |
| Age | 0.331 | |||
| <50 | 28 | 17 | 11 | |
| ≥50 | 39 | 19 | 20 | |
| Tumor size (cm) | 0.036 | |||
| <5 | 35 | 21 | 14 | |
| ≥5 | 32 | 11 | 21 | |
| Differential grade | 0.408 | |||
| Poor | 18 | 10 | 8 | |
| Middle | 23 | 14 | 9 | |
| Well | 26 | 11 | 15 | |
| LN metastasis | 0.193 | |||
| Positive | 25 | 16 | 9 | |
| Negative | 42 | 20 | 22 | |
| TNM stage | 0.026 | |||
| I | 28 | 20 | 8 | |
| II | 19 | 13 | 6 | |
| III | 20 | 7 | 13 | |
LN, lymph node; TNM, tumor, node, metastasis.